8-hydroxy quinoline derivatives for enhancing telomerase reverse transcriptase (TERT) expression
US-12168019-B1 · Dec 17, 2024 · US
Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
US8993535B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8993535-B2 |
| Application number | US-201013393571-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 27, 2010 |
| Priority date | Sep 4, 2009 |
| Publication date | Mar 31, 2015 |
| Grant date | Mar 31, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The compounds are of the class of pyrimidine analogs useful for treating cancer, for example:
First claim
Opening claim text (preview).
What is claimed is: 1. A compound or a pharmaceutically acceptable salt thereof, said compound being represented by Formula V: wherein: G is H or halo; X is selected from the group consisting of H, F, OR 2 and alkyl; Y is selected from the group consisting of H, F, OR 2 and alkyl; with the proviso that when X═Y═OR 2 , R 2 cannot be H;…
Assignees
Inventors
Classifications
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
- A61K31/70Primary
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8993535B2 cover?
- The compounds are of the class of pyrimidine analogs useful for treating cancer, for example:
- Who is the assignee on this patent?
- Popovici-Muller Janeta, Guzi Timothy J, Rosner Kristin E, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/70. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).